Combined antiretroviral and anti-tuberculosis drug resistance following incarceration

被引:0
|
作者
Stott, K. E. [1 ]
de Oliviera, T. [1 ,2 ]
Lessells, R. J. [1 ,3 ]
机构
[1] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa
[2] UCL, Res Dept Infect, London, England
[3] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England
基金
英国惠康基金;
关键词
SUB-SAHARAN AFRICA; SOUTH-AFRICA; HIV; TUBERCULOSIS; THERAPY; PRISON; INDIVIDUALS; INFECTION; MUTATIONS; CELL;
D O I
10.7196/SAJHIVMED.957
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We describe a case of HIV/tuberculosis (TB) co-infection from KwaZulu-Natal, South Africa, characterised by drug resistance in both pathogens. The development of drug resistance was linked temporally to two periods of incarceration. This highlights the urgent need for improved integration of HIV/TB control strategies within prison health systems and within the broader public health framework
引用
收藏
页码:135 / 137
页数:3
相关论文
共 50 条
  • [21] Nationwide anti-tuberculosis drug resistance survey in the Republic of Azerbaijan
    Akhundova, Irada
    Mammadbekov, Eljan
    Seyfaddinova, Mehriban
    Aliyeva, Naila
    Malikova, Khanim
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [22] Anti-tuberculosis drug therapy in mice of different inbred strains
    Nikonenko, Boris V.
    Einck, Leo
    Nacy, Carol A.
    INFECTION GENETICS AND EVOLUTION, 2010, 10 (07) : 1151 - 1154
  • [23] The epidemiology of tuberculosis and resistance to anti-tuberculosis drugs
    Khaled, NA
    Enarson, D
    Billo, N
    REVUE DES MALADIES RESPIRATOIRES, 1997, 14 : S8 - S18
  • [24] Impact of three empirical anti-tuberculosis treatment strategies for people initiating antiretroviral therapy
    Van Rie, A.
    Westreich, D.
    Sanne, I.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (11) : 1340 - 1346
  • [25] The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018
    Mutayoba, Beatrice Kemilembe
    Ershova, Julia
    Lyamuya, Eligius
    Hoelscher, Michael
    Heinrich, Norbert
    Kilale, Andrew Martin
    Range, Nyagosya Segere
    Ngowi, Benard James
    Ntinginya, Nyanda Elias
    Mfaume, Saidi Mwinjuma
    Nkiligi, Emmanuel
    Doulla, Basra
    Lyimo, Johnson
    Kisonga, Riziki
    Kingalu, Amri
    Lema, Yakobo
    Kondo, Zuwena
    Pletschette, Michel
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2022, 27 (10) : 891 - 901
  • [26] The Fourth National Anti-Tuberculosis Drug Resistance Survey in Viet Nam
    Nhung, N. V.
    Hoa, N. B.
    Sy, D. N.
    Hennig, C. M.
    Dean, A. S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (06) : 670 - 675
  • [27] Trend of anti-tuberculosis drug resistance in Korea, 1994-2004
    Bai, G-H.
    Park, Y-K.
    Choi, Y-W.
    Bai, J-I.
    Kim, H-J.
    Chang, C. L.
    Lee, J-K.
    Kim, S. J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (05) : 571 - 576
  • [28] Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997
    Bretzel, G
    Aziz, M
    Wendl-Richter, U
    Adatu, F
    Aisu, T
    van Wijnen, A
    Sticht-Groh, V
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (09) : 810 - 815
  • [29] Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis
    Laghari, Madeeha
    Talpur, Bandeh Ali
    Sulaiman, Syed Azhar Syed
    Khan, Amer Hayat
    Bhatti, Zohra
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2020, 9 (03) : 281 - 288
  • [30] Advantages and drawbacks of expectoration decontamination methods for tuberculosis and anti-tuberculosis drug resistance diagnosis
    Zingue, Dezemon
    Hien, Herve
    Meda, Nicolas
    Zida, Sylvie
    Kabore, Antoinette
    Sanou, Adama
    Ouedraogo, Abdoul-Salam
    Gomgnimbou, Michel
    Diande, Souba
    Tarnagda, Zekiba
    Godreuil, Sylvain
    ANNALES DE BIOLOGIE CLINIQUE, 2013, 71 (03) : 283 - 291